Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $129B | +$2.71B | 171 | 4.57% | Increased |
|
| 2 |
BlackRock
New York
| $120B | +$7.16B | 188 | 4.8% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $73.9B | +$2.63B | 141 | 5.37% | Increased |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $34.9B | +$2.45B | 119 | 3.84% | Increased |
|
| 5 |
Wellington Management Group
Boston,
Massachusetts
| $30.9B | -$666M | 53 | 6.89% | Reduced |
|
| 6 |
Capital Research Global Investors
Los Angeles,
California
| $24B | +$2.52B | 14 | 7.6% | Increased |
|
| 7 |
Capital World Investors
Los Angeles,
California
| $23.7B | +$251M | 24 | 5.74% | Increased |
|
| 8 |
Geode Capital Management
Boston,
Massachusetts
| $23.4B | +$166M | 187 | 5.01% | Increased |
|
| 9 |
T. Rowe Price Associates
Baltimore,
Maryland
| $23.1B | +$880M | 81 | 2.9% | Increased |
|
| 10 |
Capital International Investors
Los Angeles,
California
| $21.4B | +$1.27B | 25 | 7.01% | Increased |
|
| 11 |
Northern Trust
Chicago,
Illinois
| $20.1B | +$737M | 171 | 4.76% | Increased |
|
| 12 |
Bank of America
Charlotte,
North Carolina
| $19.8B | -$54.7M | 177 | 3.01% | Reduced |
|
| 13 |
JP Morgan Chase
New York
| $19B | +$827M | 157 | 3.67% | Increased |
|
| 14 |
Bank of New York Mellon
New York
| $16.8B | -$37.9M | 142 | 4.47% | Reduced |
|
| 15 |
Norges Bank
Oslo,
Norway
| $16B | +$187M | 61 | 4.6% | Increased |
|
| 16 |
BBA
Baker Bros. Advisors
New York
| $14.6B | -$245M | 35 | 64.53% | Reduced |
|
| 17 |
Primecap Management
Pasadena,
California
| $13.7B | -$462M | 19 | 11.74% | Reduced |
|
| 18 |
Morgan Stanley
New York
| $12.5B | +$499M | 203 | 2.78% | Increased |
|
| 19 |
Wells Fargo
San Francisco,
California
| $12.1B | +$424M | 186 | 3.52% | Increased |
|
| 20 |
Nuveen
Charlotte,
North Carolina
| $11.5B | -$516M | 120 | 4.7% | Reduced |
|
| 21 |
Renaissance Technologies
New York
| $10.7B | -$1.65B | 150 | 9.22% | Reduced |
|
| 22 |
Ameriprise
Minneapolis,
Minnesota
| $9.75B | +$131M | 75 | 4.18% | Increased |
|
| 23 |
Legal & General Group
London,
United Kingdom
| $9.63B | +$327M | 126 | 4.66% | Increased |
|
| 24 |
Franklin Resources
San Mateo,
California
| $9.49B | +$535M | 38 | 4.89% | Increased |
|
| 25 |
Goldman Sachs
New York
| $9.49B | -$880M | 141 | 2.88% | Reduced |
|